114 related articles for article (PubMed ID: 38492813)
21. Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
Mishra MV; Khairnar R; Bentzen SM; Larson G; Tsai H; Sinesi C; Vargas C; Laramore G; Rossi C; Rosen L; Zhu M; Hartsell W
Clin Transl Radiat Oncol; 2019 Nov; 19():80-86. PubMed ID: 31650043
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy.
Aibe N; Demizu Y; Sulaiman NS; Matsuo Y; Mima M; Nagano F; Terashima K; Tokumaru S; Hayakawa T; Suga M; Daimon T; Suzuki G; Hideya Y; Yamada K; Sasaki R; Fuwa N; Okimoto T
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):972-979. PubMed ID: 29485077
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
[TBL] [Abstract][Full Text] [Related]
24. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation.
Choi JI; Khan AJ; Powell SN; McCormick B; Lozano AJ; Del Rosario G; Mamary J; Liu H; Fox P; Gillespie E; Braunstein LZ; Mah D; Cahlon O
Radiother Oncol; 2021 Dec; 165():142-151. PubMed ID: 34688807
[TBL] [Abstract][Full Text] [Related]
25. High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy.
Carrasquilla M; Paudel N; Collins BT; Anderson E; Krochmal R; Margolis M; Balawi A; DeBlois D; Giaccone G; Kim C; Liu S; Lischalk JW
Adv Radiat Oncol; 2023; 8(2):101125. PubMed ID: 36578277
[TBL] [Abstract][Full Text] [Related]
26. A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity.
Uchinami Y; Katoh N; Suzuki R; Kanehira T; Tamura M; Takao S; Matsuura T; Miyamoto N; Fujita Y; Koizumi F; Taguchi H; Yasuda K; Nishioka K; Yokota I; Kobashi K; Aoyama H
Clin Transl Radiat Oncol; 2022 Jul; 35():70-75. PubMed ID: 35633653
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
28. Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses.
Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
Front Oncol; 2020; 10():572493. PubMed ID: 33102230
[No Abstract] [Full Text] [Related]
29. Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients' registration database, Proton-Net.
Yamazaki H; Shibuya K; Kimoto T; Suzuki M; Murakami M; Terashima K; Okimoto T; Iizumi T; Sakurai H; Wakatsuki M; Suzuki O; Katoh N; Arimura T; Ogino T; Takagi M; Araya M; Waki T; Matsumoto S; Ogino H; Fukumoto T; Ohtsuka M
Clin Transl Radiat Oncol; 2023 Jul; 41():100634. PubMed ID: 37234735
[TBL] [Abstract][Full Text] [Related]
30. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
[TBL] [Abstract][Full Text] [Related]
31. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
32. Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.
Vítek P; Kubeš J; Vondráček V; Andrlik M; Navrátíl M; Zapletal R; Haas A; Dědečková K; Ondrová B; Grebenyuk A; Rosina J
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008349
[No Abstract] [Full Text] [Related]
33. Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry.
Eckstein J; Choi JI; Lozano A; Ohri N; Press R; Hasan S; Kabarriti R; Chang J; Urbanic J; Durci M; Mohammed N; Stevens C; Tsai H; Apisarnthanarax S; Regine W; Vargas C; Nichols R; Herman J; Simone CB; Chhabra A
Adv Radiat Oncol; 2023; 8(5):101250. PubMed ID: 37408677
[TBL] [Abstract][Full Text] [Related]
34. Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy.
Pasalic D; Ludmir EB; Allen PK; Thaker NG; Chapman BV; Hanna EY; Su SY; Ferrarotto R; Glisson BS; Reddy JP; Brandon Gunn G; Fuller CD; Phan J; Rosenthal DI; Morrison WH; Garden AS; Frank SJ
Radiother Oncol; 2020 Jul; 148():258-266. PubMed ID: 32417351
[TBL] [Abstract][Full Text] [Related]
35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant proton beam therapy in patients with grade 2 meningiomas.
Wilson TA; Kang JI; Huang L; Vacaru A; Martins KN; Boling WW
Surg Neurol Int; 2024; 15():62. PubMed ID: 38468681
[TBL] [Abstract][Full Text] [Related]
37. Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons.
Forsthoefel M; Hankins R; Ballew E; Frame C; DeBlois D; Pang D; Krishnan P; Unger K; Kowalczyk K; Lynch J; Dritschilo A; Collins SP; Lischalk JW
Int J Part Ther; 2022; 9(1):28-41. PubMed ID: 35774493
[TBL] [Abstract][Full Text] [Related]
38. High-Dose Proton Beam-Based Radiation Therapy in the Management of Extracranial Chondrosarcomas.
Bhatt AD; Jacobson A; Lee RY; Giraud C; Schwab JH; Hornicek FJ; Nielsen P; Choy E; Harmon D; DeLaney TF; Chen YE
Int J Part Ther; 2017; 3(3):373-381. PubMed ID: 31772986
[TBL] [Abstract][Full Text] [Related]
39. A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors.
Yu NY; Gamez ME; Hartsell WF; Tsai HK; Laramore GE; Larson GL; Simone CB; Rossi C; Katz SR; Buras MR; Golafshar MA; Vargas CE; Patel SH
Adv Radiat Oncol; 2019; 4(4):689-698. PubMed ID: 31673662
[TBL] [Abstract][Full Text] [Related]
40. A retrospective study of late adverse events in proton beam therapy for prostate cancer.
Makishima H; Ishikawa H; Tanaka K; Mori Y; Mizumoto M; Ohnishi K; Aihara T; Fukumitsu N; Okumura T; Sakurai H
Mol Clin Oncol; 2017 Oct; 7(4):547-552. PubMed ID: 29046789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
